Mini-Pill (Norethisterone)

Norethisterone, the active ingredient in Mini-Pill, is a progestogen presented as an oral tablet for oral use. It is employed as a progestin‑only oral contraceptive and for the management of certain menstrual disorders in women of reproductive age.

GNH USA supplies Mini-Pill as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Norethisterone is used in the progestogen class for contraception and menstrual regulation. - Contraception: provides progestin‑only oral contraception to prevent pregnancy. - Irregular menstrual bleeding: helps normalize cycle length and flow. - Menstrual disorders: reduces dysmenorrhea and other hormone‑related symptoms.

Norethisterone may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Irregular bleeding or spotting. - Headache. - Nausea or abdominal discomfort. - Breast tenderness. - Mood changes. - Weight gain.

Serious or Rare Side Effects: - Deep vein thrombosis or pulmonary embolism. - Severe hypertension. - Liver dysfunction or jaundice. - Allergic reactions such as rash or angioedema. - Visual disturbances. - Unexplained vaginal bleeding.

Before prescribing Mini-Pill, clinicians should consider patient history and risk factors. - Thromboembolic risk: avoid in patients with a history of clotting disorders. - Cardiovascular disease: assess blood pressure and cardiac status. - Liver disease: use with caution in hepatic impairment. - Smoking: advise cessation, especially in women over 35. - Pregnancy and lactation: contraindicated during pregnancy; discuss risks if breastfeeding. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and light.

Norethisterone can interact with several drug classes, altering its efficacy or safety.

Major Interactions (Avoid): - Antiepileptic enzymes inducers (e.g., carbamazepine, phenytoin): may reduce contraceptive effectiveness. - Rifampicin or other strong CYP3A4 inducers: can lower plasma levels.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole): may increase hormone concentrations. - Antiretroviral protease inhibitors: may affect metabolism. - St. John’s wort: potential reduction in efficacy. - Certain antibiotics (e.g., griseofulvin): possible modest effect on hormone levels.